Comparability preview
Build the board report — $49 →
Cancer Research And Biostatistics
EIN 911828539 · WA · NTEE H30 · revenue $12,083,341 · FY 2023-12-31
$
Pick the role and type the pay your board is considering — everything below updates as you type. We only compare against the same role.
77th percentile
We compared this Executive Director / CEO's pay to 48 similar medical research nonprofits of about the same size, adjusted for WA cost of living and inflation.
HOERING ANTJE · reported title "CEO & BOARD PRESIDENT" — selected as the highest-paid individual; verify the role.
How we chose them
Every comparable organization in the band — 48 in total — matched by Same NTEE major group (H), nationwide + budget 0.77–1.3× revenue, and selected by rule, not hand-picked. Peer pay is normalized to WA cost of living (BEA Regional Price Parities) and to the subject's filing year (CPI-U). Full methodology →
| Organization | State | Revenue | Total comp | Filing |
|---|---|---|---|---|
| Scleroderma Research Foundation | CA | $12,173,161 | $215,312 | 990 → |
| Cedars Sinai Intellectual Property | CA | $12,258,610 | $182,896 | 990 → |
| Cure Childhood Cancer Inc | GA | $11,822,681 | $417,453 | 990 → |
| Count Me In Inc | MA | $11,767,611 | $182,440 | 990 → |
| The Jacobs Institute Inc | NY | $12,451,121 | $593,858 | 990 → |
| 🔒 +43 more comparable organizations — the full peer set, sources, and CSV export are included in your board report. | ||||
Generate the board-ready determination
A formatted PDF with the full 48-organization peer set, the distribution, the methodology, and ready-to-adopt 26 CFR 53.4958-6 board-minutes language — timestamped to attach to your minutes. A screenshot of a webpage isn't board minutes.